Displaying drugs 1851 - 1875 of 6039 in total
FB-101
FB-101 is a c-Abl inhibitor. Developed by 1st Biotherapeutics, it is being investigated for the treatment of neurological disorders, such as Parkinson's Disease and amyotrophic lateral sclerosis (ALS).
Experimental
Investigational
Matched Synonyms: … FB 101 …
Matched Name: … FB-101 …
Matched Description: … FB-101 is a c-Abl inhibitor. …
Matched Name: … FB-101 …
Matched Description: … FB-101 is a c-Abl inhibitor. …
ACT-101
ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.
Investigational
Matched Synonyms: … ACT 101 …
Matched Name: … ACT-101 …
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
Matched Name: … ACT-101 …
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
EGT-101
EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the human sulfamidase (SGSH) transgene. Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type A.
Investigational
Matched Synonyms: … EGT 101 …
Matched Name: … EGT-101 …
Matched Description: … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of …
Matched Name: … EGT-101 …
Matched Description: … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of …
Technetium Tc-99m arcitumomab
Reduced Fab fragment of the murine IgG1 monoclonal antibody IMMU-4 (also called NP-4) with specificity for carcinoembryonic antigen (CEA) covalently labeled with Technitium 99. The molecule has a molecular weight of ~54,000 Daltons.
Experimental
Matched Synonyms: … Arcitumomab technetium-99m ... Technetium-99m arcitumomab ... Technetium Tc 99m arcitumomab …
Matched Name: … Technetium Tc-99m arcitumomab …
Matched Description: … called NP-4) with specificity for carcinoembryonic antigen (CEA) covalently labeled with Technitium 99 …
Matched Name: … Technetium Tc-99m arcitumomab …
Matched Description: … called NP-4) with specificity for carcinoembryonic antigen (CEA) covalently labeled with Technitium 99 …
Technetium Tc-99m etifenin
Experimental
Matched Synonyms: … Technetium (99m Tc) etifenin …
Matched Name: … Technetium Tc-99m etifenin …
Matched Name: … Technetium Tc-99m etifenin …
Technetium Tc-99m epratuzumab
Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).
Investigational
Matched Synonyms: … TECHNETIUM TC 99M EPRATUZUMAB …
Matched Name: … Technetium Tc-99m epratuzumab …
Matched Description: … Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal …
Matched Name: … Technetium Tc-99m epratuzumab …
Matched Description: … Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal …
Technetium Tc-99m ciprofloxacin
99mTc-Ciprofloxacin is a new formulation of ciprofloxacin (INFECTON), being investigated as a radioimaging agent for the potential diagnosis of infection, including fever of unknown origin, osteomyelitis, wound infection, abdominal abscess, pneumonia, appendicitis and tuberculosis. INFECTON combines the widely used antibiotic, ciprofloxacin, with Technetium ((99m)Tc), the most commonly used radioisotope in...
Investigational
Matched Synonyms: … Technetium Tc 99m ciprofloxacin …
Matched Name: … Technetium Tc-99m ciprofloxacin …
Matched Description: … INFECTON combines the widely used antibiotic, ciprofloxacin, with Technetium ((99m)Tc), the most commonly …
Matched Name: … Technetium Tc-99m ciprofloxacin …
Matched Description: … INFECTON combines the widely used antibiotic, ciprofloxacin, with Technetium ((99m)Tc), the most commonly …
DYN-101
DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Investigational
Matched Synonyms: … DYN 101 …
Matched Name: … DYN-101 …
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
Matched Name: … DYN-101 …
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
AMY-101
AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).
Investigational
Matched Synonyms: … AMY 101 …
Matched Name: … AMY-101 …
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
Matched Name: … AMY-101 …
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
LAX-101
LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements.
Investigational
Matched Name: … LAX-101 …
Matched Description: … LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. ... The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. ... The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements …
Matched Description: … LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. ... The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. ... The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements …
AVB-101
AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene.
Investigational
Matched Name: … AVB-101 …
Matched Description: … AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene. …
Matched Description: … AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene. …
AP-101
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
Matched Name: … AP-101 …
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
ATSN-101
ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D)
Investigational
Matched Name: … ATSN-101 …
Matched Description: … ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5 …
Matched Description: … ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5 …
AMP-101
AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
Investigational
Matched Name: … AMP-101 …
Matched Description: … AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human …
Matched Description: … AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human …
CUDC-101
CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others.
Investigational
Matched Name: … CUDC-101 …
Matched Description: … CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer …
Matched Description: … CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer …
CYNK-101
CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational
Matched Name: … CYNK-101 …
Matched Description: … CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy …
Matched Description: … CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy …
ST-101
ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. ST101 has been used in trials studying the treatment of Essential Tremor and Alzheimer's Disease.
Investigational
Matched Synonyms: … ST-101 (D-AMINO ACID PEPTIDE) …
Matched Name: … ST-101 …
Matched Description: … ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. …
Matched Name: … ST-101 …
Matched Description: … ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. …
MYR-101
MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy intended to treat Canavan disease. Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain. It is caused by a mutation in the aspartoacylase gene (ASPA), which leads to a deficiency of the...
Investigational
Matched Name: … MYR-101 …
Matched Description: … MYR-101 targets oligodendrocytes and delivers functional ASPA. ... MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy ... [L43567] The FDA has granted MYR-101 Fast Track, Rare Pediatric Disease (RPD), and Orphan Drug designations …
Matched Description: … MYR-101 targets oligodendrocytes and delivers functional ASPA. ... MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy ... [L43567] The FDA has granted MYR-101 Fast Track, Rare Pediatric Disease (RPD), and Orphan Drug designations …
Biomed 101
Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. Biomed 101 is a solid. Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity.
Investigational
Matched Name: … Biomed 101 …
Matched Description: … Biomed 101 is a solid. ... Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma ... Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity …
Matched Description: … Biomed 101 is a solid. ... Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma ... Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity …
AV-101
AV-101 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Matched Name: … AV-101 …
Matched Description: … AV-101 has been used in trials studying the treatment of Neuropathic Pain. …
Matched Description: … AV-101 has been used in trials studying the treatment of Neuropathic Pain. …
Displaying drugs 1851 - 1875 of 6039 in total